Wird geladen...
Whether, when, how, and how much? General public’s and cancer patients’ views about the disclosure of genomic secondary findings
BACKGROUND: Data on the modalities of disclosing genomic secondary findings (SFs) remain scarce. We explore cancer patients’ and the general public’s perspectives about disclosing genomic SFs and the modalities of such disclosure. METHODS: Sixty-one cancer patients (n = 29) and members of the public...
Gespeichert in:
| Veröffentlicht in: | BMC Med Genomics |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8236159/ https://ncbi.nlm.nih.gov/pubmed/34174888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12920-021-01016-8 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|